News

Novartis in Focus Based in Basel, Novartis (NVS) is in the Medical sector, and so far this year, shares have seen a price change of 21.05%. Currently paying a dividend of $2.6 per share, the ...
US efforts to rein in the Basel Committee’s focus on climate risks were met with a rare show of resistance this week, ... May 16, 2025 at 7:28 AM EDT. Save.
Based in Basel, Switzerland, Novartis is one of the largest pharmaceutical companies in the world. Its revenues for 2023 came to $45.44 billion . One of its best-known products is Entresto , a ...
Novartis zieht sich nach 21 Jahren als Hauptsponsor des FC Basel zurück. Der neue Trikotsponsor des FCB ist der Finanzdienstleister Bitpanda. Bitpanda ist bekannt für den Handel mit ...
Novartis raised its 2025 outlook after its core operating profit rose 23% on year, boosted by strong demand for its key drugs. The Basel-based drugmaker is bracing for headwinds from the U.S ...
European drugmaker Novartis (NVS), best known for blockbuster drugs like Entresto, Cosentyx, and Kesimpta, just announced a major U.S. investment. The $200 billion pharma company intends to invest ...
Der Basler Pharmakonzern Novartis investiert 23 Milliarden Dollar in US-Standorte. Experten zeigen sich besorgt über die Auswirkungen auf den Pharma-Forschungsstandort Basel.
Investing.com -- Novartis (SIX: NOVN) on Friday reported its fourth-quarter and full-year 2024 financial results.Fourth-quarter net sales reached $13.2 billion, a 16% increase in constant currency ...
Novartis won an order from a U.S. appeals court in Washington on Thursday temporarily blocking drugmaker MSN Pharmaceuticals from ... January 16, 2025 10:51 PM UTC Updated January 16, 2025 ...
Basel-Stadt kauft vier Liegenschaften von Novartis Die Regierung meldet den Erwerb von vier Schlüsselparzellen für die Entwicklung des Kleinbasel. Darunter das Horburg-Parking.
The European Broadcasting Union (EBU) is delighted to announce Novartis as an ‘Official Partner’ for the 69th Eurovision Song Contest when it’s hosted in their hometown in Basel, Switzerland, next May ...